quinazolines has been researched along with Immunologic Deficiency Syndromes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aiuti, A; Ariganello, P; Attardi, E; Brigida, I; Cancrini, C; Chiriaco, M; Cittaro, D; Di Cesare, S; Di Matteo, G; Finocchi, A; Fraziano, M; Giannelli, S; Lazarevic, D; Palma, P; Rossi, P; Santilli, V; Scarselli, A; Stupka, E; Taus, F | 1 |
| De Groot, R; Neijens, HJ; Smit, MJ; Van der Voort, E; Van Dongen, JJ; Whitfield, LR | 1 |
2 other study(ies) available for quinazolines and Immunologic Deficiency Syndromes
| Article | Year |
|---|---|
The case of an APDS patient: Defects in maturation and function and decreased in vitro anti-mycobacterial activity in the myeloid compartment.
Topics: Adenine; B-Lymphocytes; Cell Differentiation; Class I Phosphatidylinositol 3-Kinases; Dendritic Cells; Humans; Immunologic Deficiency Syndromes; In Vitro Techniques; Inflammation; Lymphopenia; Macrophages; Male; Mycobacterium bovis; Primary Immunodeficiency Diseases; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; TOR Serine-Threonine Kinases; Young Adult | 2017 |
Trimetrexate efficacy and pharmacokinetics during treatment of refractory Pneumocystis carinii pneumonia in an infant with severe combined immunodeficiency disease.
Topics: Antifungal Agents; Drug Combinations; Glucuronates; Humans; Immunologic Deficiency Syndromes; Infant; Infusions, Intravenous; Leucovorin; Male; Pentamidine; Pneumonia, Pneumocystis; Quinazolines; Respiratory Insufficiency; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate | 1990 |